▶ 調査レポート

レボブピバカイン塩酸塩のグローバル市場インサイト・予測(~2027年)

• 英文タイトル:Global Levobupivacaine Hydrochloride Market Insights and Forecast to 2027

QYResearchが調査・発行した産業分析レポートです。レボブピバカイン塩酸塩のグローバル市場インサイト・予測(~2027年) / Global Levobupivacaine Hydrochloride Market Insights and Forecast to 2027 / QY2112C00311資料のイメージです。• レポートコード:QY2112C00311
• 出版社/出版日:QYResearch / 2021年12月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、96ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥686,000 (USD4,900)▷ お問い合わせ
  Multi User¥1,029,000 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,372,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査資料はレボブピバカイン塩酸塩の世界市場の現状について調査・分析し、2027年までの市場を予測しました。レボブピバカイン塩酸塩の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(99%純度、その他)、用途別市場規模(手術用硬膜外ブロック、その他)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・レボブピバカイン塩酸塩の世界市場概要
・メーカー別の競争状況、市場シェア
・レボブピバカイン塩酸塩の種類別市場規模:99%純度、その他
・レボブピバカイン塩酸塩の用途別市場規模:手術用硬膜外ブロック、その他
・北米のレボブピバカイン塩酸塩市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ)
・ヨーロッパのレボブピバカイン塩酸塩市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス)
・アジアのレボブピバカイン塩酸塩市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国)
・中南米のレボブピバカイン塩酸塩市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル)
・中東・アフリカのレボブピバカイン塩酸塩市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア)
・企業情報:Rundu Pharma、Dishman Carbogen Amcis、Recipharm、Shanghai OSD、Nanjin Yihua、ASK Pharm、Jiangsu Hengrui Medicine
・レボブピバカイン塩酸塩のバリューチェーン・販売チャネル分析
・レボブピバカイン塩酸塩の世界市場動向

Market Analysis and Insights: Global Levobupivacaine Hydrochloride Market
The global Levobupivacaine Hydrochloride market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Levobupivacaine Hydrochloride Scope and Segment
Levobupivacaine Hydrochloride market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Levobupivacaine Hydrochloride market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
99% Purity
Other

Segment by Application
Surgical Epidural Block
Other

By Company
Rundu Pharma
Dishman Carbogen Amcis
Recipharm
Shanghai OSD
Nanjin Yihua
ASK Pharm
Jiangsu Hengrui Medicine

Production by Region
North America
Europe
China
Japan

Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Levobupivacaine Hydrochloride Product Introduction
1.2 Market by Type
1.2.1 Global Levobupivacaine Hydrochloride Market Size Growth Rate by Type
1.2.2 99% Purity
1.2.3 Other
1.3 Market by Application
1.3.1 Global Levobupivacaine Hydrochloride Market Size Growth Rate by Application
1.3.2 Surgical Epidural Block
1.3.3 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Levobupivacaine Hydrochloride Production
2.1 Global Levobupivacaine Hydrochloride Production Capacity (2016-2027)
2.2 Global Levobupivacaine Hydrochloride Production by Region: 2016 VS 2021 VS 2027
2.3 Global Levobupivacaine Hydrochloride Production by Region
2.3.1 Global Levobupivacaine Hydrochloride Historic Production by Region (2016-2021)
2.3.2 Global Levobupivacaine Hydrochloride Forecasted Production by Region (2022-2027)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan

3 Global Levobupivacaine Hydrochloride Sales in Volume & Value Estimates and Forecasts
3.1 Global Levobupivacaine Hydrochloride Sales Estimates and Forecasts 2016-2027
3.2 Global Levobupivacaine Hydrochloride Revenue Estimates and Forecasts 2016-2027
3.3 Global Levobupivacaine Hydrochloride Revenue by Region: 2016 VS 2021 VS 2027
3.4 Global Top Levobupivacaine Hydrochloride Regions by Sales
3.4.1 Global Top Levobupivacaine Hydrochloride Regions by Sales (2016-2021)
3.4.2 Global Top Levobupivacaine Hydrochloride Regions by Sales (2022-2027)
3.5 Global Top Levobupivacaine Hydrochloride Regions by Revenue
3.5.1 Global Top Levobupivacaine Hydrochloride Regions by Revenue (2016-2021)
3.5.2 Global Top Levobupivacaine Hydrochloride Regions by Revenue (2022-2027)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa

4 Competition by Manufactures
4.1 Global Levobupivacaine Hydrochloride Production Capacity by Manufacturers
4.2 Global Levobupivacaine Hydrochloride Sales by Manufacturers
4.2.1 Global Top Levobupivacaine Hydrochloride Manufacturers by Sales (2016-2021)
4.2.2 Global Top Levobupivacaine Hydrochloride Manufacturers Market Share by Sales (2016-2021)
4.2.3 Global Top 10 and Top 5 Companies by Levobupivacaine Hydrochloride Sales in 2020
4.3 Global Levobupivacaine Hydrochloride Revenue by Manufacturers
4.3.1 Global Top Levobupivacaine Hydrochloride Manufacturers by Revenue (2016-2021)
4.3.2 Global Top Levobupivacaine Hydrochloride Manufacturers Market Share by Revenue (2016-2021)
4.3.3 Global Top 10 and Top 5 Companies by Levobupivacaine Hydrochloride Revenue in 2020
4.4 Global Levobupivacaine Hydrochloride Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Levobupivacaine Hydrochloride Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Levobupivacaine Hydrochloride Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type
5.1 Global Levobupivacaine Hydrochloride Sales by Type
5.1.1 Global Levobupivacaine Hydrochloride Historical Sales by Type (2016-2021)
5.1.2 Global Levobupivacaine Hydrochloride Forecasted Sales by Type (2022-2027)
5.1.3 Global Levobupivacaine Hydrochloride Sales Market Share by Type (2016-2027)
5.2 Global Levobupivacaine Hydrochloride Revenue by Type
5.2.1 Global Levobupivacaine Hydrochloride Historical Revenue by Type (2016-2021)
5.2.2 Global Levobupivacaine Hydrochloride Forecasted Revenue by Type (2022-2027)
5.2.3 Global Levobupivacaine Hydrochloride Revenue Market Share by Type (2016-2027)
5.3 Global Levobupivacaine Hydrochloride Price by Type
5.3.1 Global Levobupivacaine Hydrochloride Price by Type (2016-2021)
5.3.2 Global Levobupivacaine Hydrochloride Price Forecast by Type (2022-2027)

6 Market Size by Application
6.1 Global Levobupivacaine Hydrochloride Sales by Application
6.1.1 Global Levobupivacaine Hydrochloride Historical Sales by Application (2016-2021)
6.1.2 Global Levobupivacaine Hydrochloride Forecasted Sales by Application (2022-2027)
6.1.3 Global Levobupivacaine Hydrochloride Sales Market Share by Application (2016-2027)
6.2 Global Levobupivacaine Hydrochloride Revenue by Application
6.2.1 Global Levobupivacaine Hydrochloride Historical Revenue by Application (2016-2021)
6.2.2 Global Levobupivacaine Hydrochloride Forecasted Revenue by Application (2022-2027)
6.2.3 Global Levobupivacaine Hydrochloride Revenue Market Share by Application (2016-2027)
6.3 Global Levobupivacaine Hydrochloride Price by Application
6.3.1 Global Levobupivacaine Hydrochloride Price by Application (2016-2021)
6.3.2 Global Levobupivacaine Hydrochloride Price Forecast by Application (2022-2027)

7 North America
7.1 North America Levobupivacaine Hydrochloride Market Size by Type
7.1.1 North America Levobupivacaine Hydrochloride Sales by Type (2016-2027)
7.1.2 North America Levobupivacaine Hydrochloride Revenue by Type (2016-2027)
7.2 North America Levobupivacaine Hydrochloride Market Size by Application
7.2.1 North America Levobupivacaine Hydrochloride Sales by Application (2016-2027)
7.2.2 North America Levobupivacaine Hydrochloride Revenue by Application (2016-2027)
7.3 North America Levobupivacaine Hydrochloride Sales by Country
7.3.1 North America Levobupivacaine Hydrochloride Sales by Country (2016-2027)
7.3.2 North America Levobupivacaine Hydrochloride Revenue by Country (2016-2027)
7.3.3 United States
7.3.4 Canada

8 Europe
8.1 Europe Levobupivacaine Hydrochloride Market Size by Type
8.1.1 Europe Levobupivacaine Hydrochloride Sales by Type (2016-2027)
8.1.2 Europe Levobupivacaine Hydrochloride Revenue by Type (2016-2027)
8.2 Europe Levobupivacaine Hydrochloride Market Size by Application
8.2.1 Europe Levobupivacaine Hydrochloride Sales by Application (2016-2027)
8.2.2 Europe Levobupivacaine Hydrochloride Revenue by Application (2016-2027)
8.3 Europe Levobupivacaine Hydrochloride Sales by Country
8.3.1 Europe Levobupivacaine Hydrochloride Sales by Country (2016-2027)
8.3.2 Europe Levobupivacaine Hydrochloride Revenue by Country (2016-2027)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia

9 Asia Pacific
9.1 Asia Pacific Levobupivacaine Hydrochloride Market Size by Type
9.1.1 Asia Pacific Levobupivacaine Hydrochloride Sales by Type (2016-2027)
9.1.2 Asia Pacific Levobupivacaine Hydrochloride Revenue by Type (2016-2027)
9.2 Asia Pacific Levobupivacaine Hydrochloride Market Size by Application
9.2.1 Asia Pacific Levobupivacaine Hydrochloride Sales by Application (2016-2027)
9.2.2 Asia Pacific Levobupivacaine Hydrochloride Revenue by Application (2016-2027)
9.3 Asia Pacific Levobupivacaine Hydrochloride Sales by Region
9.3.1 Asia Pacific Levobupivacaine Hydrochloride Sales by Region (2016-2027)
9.3.2 Asia Pacific Levobupivacaine Hydrochloride Revenue by Region (2016-2027)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia

10 Latin America
10.1 Latin America Levobupivacaine Hydrochloride Market Size by Type
10.1.1 Latin America Levobupivacaine Hydrochloride Sales by Type (2016-2027)
10.1.2 Latin America Levobupivacaine Hydrochloride Revenue by Type (2016-2027)
10.2 Latin America Levobupivacaine Hydrochloride Market Size by Application
10.2.1 Latin America Levobupivacaine Hydrochloride Sales by Application (2016-2027)
10.2.2 Latin America Levobupivacaine Hydrochloride Revenue by Application (2016-2027)
10.3 Latin America Levobupivacaine Hydrochloride Sales by Country
10.3.1 Latin America Levobupivacaine Hydrochloride Sales by Country (2016-2027)
10.3.2 Latin America Levobupivacaine Hydrochloride Revenue by Country (2016-2027)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Levobupivacaine Hydrochloride Market Size by Type
11.1.1 Middle East and Africa Levobupivacaine Hydrochloride Sales by Type (2016-2027)
11.1.2 Middle East and Africa Levobupivacaine Hydrochloride Revenue by Type (2016-2027)
11.2 Middle East and Africa Levobupivacaine Hydrochloride Market Size by Application
11.2.1 Middle East and Africa Levobupivacaine Hydrochloride Sales by Application (2016-2027)
11.2.2 Middle East and Africa Levobupivacaine Hydrochloride Revenue by Application (2016-2027)
11.3 Middle East and Africa Levobupivacaine Hydrochloride Sales by Country
11.3.1 Middle East and Africa Levobupivacaine Hydrochloride Sales by Country (2016-2027)
11.3.2 Middle East and Africa Levobupivacaine Hydrochloride Revenue by Country (2016-2027)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE

12 Corporate Profiles
12.1 Rundu Pharma
12.1.1 Rundu Pharma Corporation Information
12.1.2 Rundu Pharma Overview
12.1.3 Rundu Pharma Levobupivacaine Hydrochloride Sales, Price, Revenue and Gross Margin (2016-2021)
12.1.4 Rundu Pharma Levobupivacaine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Rundu Pharma Recent Developments
12.2 Dishman Carbogen Amcis
12.2.1 Dishman Carbogen Amcis Corporation Information
12.2.2 Dishman Carbogen Amcis Overview
12.2.3 Dishman Carbogen Amcis Levobupivacaine Hydrochloride Sales, Price, Revenue and Gross Margin (2016-2021)
12.2.4 Dishman Carbogen Amcis Levobupivacaine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Dishman Carbogen Amcis Recent Developments
12.3 Recipharm
12.3.1 Recipharm Corporation Information
12.3.2 Recipharm Overview
12.3.3 Recipharm Levobupivacaine Hydrochloride Sales, Price, Revenue and Gross Margin (2016-2021)
12.3.4 Recipharm Levobupivacaine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Recipharm Recent Developments
12.4 Shanghai OSD
12.4.1 Shanghai OSD Corporation Information
12.4.2 Shanghai OSD Overview
12.4.3 Shanghai OSD Levobupivacaine Hydrochloride Sales, Price, Revenue and Gross Margin (2016-2021)
12.4.4 Shanghai OSD Levobupivacaine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Shanghai OSD Recent Developments
12.5 Nanjin Yihua
12.5.1 Nanjin Yihua Corporation Information
12.5.2 Nanjin Yihua Overview
12.5.3 Nanjin Yihua Levobupivacaine Hydrochloride Sales, Price, Revenue and Gross Margin (2016-2021)
12.5.4 Nanjin Yihua Levobupivacaine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Nanjin Yihua Recent Developments
12.6 ASK Pharm
12.6.1 ASK Pharm Corporation Information
12.6.2 ASK Pharm Overview
12.6.3 ASK Pharm Levobupivacaine Hydrochloride Sales, Price, Revenue and Gross Margin (2016-2021)
12.6.4 ASK Pharm Levobupivacaine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 ASK Pharm Recent Developments
12.7 Jiangsu Hengrui Medicine
12.7.1 Jiangsu Hengrui Medicine Corporation Information
12.7.2 Jiangsu Hengrui Medicine Overview
12.7.3 Jiangsu Hengrui Medicine Levobupivacaine Hydrochloride Sales, Price, Revenue and Gross Margin (2016-2021)
12.7.4 Jiangsu Hengrui Medicine Levobupivacaine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Jiangsu Hengrui Medicine Recent Developments

13 Industry Chain and Sales Channels Analysis
13.1 Levobupivacaine Hydrochloride Industry Chain Analysis
13.2 Levobupivacaine Hydrochloride Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Levobupivacaine Hydrochloride Production Mode & Process
13.4 Levobupivacaine Hydrochloride Sales and Marketing
13.4.1 Levobupivacaine Hydrochloride Sales Channels
13.4.2 Levobupivacaine Hydrochloride Distributors
13.5 Levobupivacaine Hydrochloride Customers

14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Levobupivacaine Hydrochloride Industry Trends
14.2 Levobupivacaine Hydrochloride Market Drivers
14.3 Levobupivacaine Hydrochloride Market Challenges
14.4 Levobupivacaine Hydrochloride Market Restraints

15 Key Finding in The Global Levobupivacaine Hydrochloride Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Levobupivacaine Hydrochloride Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 99% Purity
Table 3. Major Manufacturers of Other
Table 4. Global Levobupivacaine Hydrochloride Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Levobupivacaine Hydrochloride Production by Region: 2016 VS 2021 VS 2027 (Ton)
Table 6. Global Levobupivacaine Hydrochloride Production by Region (2016-2021) & (Ton)
Table 7. Global Levobupivacaine Hydrochloride Production Market Share by Region (2016-2021)
Table 8. Global Levobupivacaine Hydrochloride Production by Region (2022-2027) & (Ton)
Table 9. Global Levobupivacaine Hydrochloride Production Market Share by Region (2022-2027)
Table 10. Global Levobupivacaine Hydrochloride Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Levobupivacaine Hydrochloride Sales by Region (2016-2021) & (Ton)
Table 12. Global Levobupivacaine Hydrochloride Sales Market Share by Region (2016-2021)
Table 13. Global Levobupivacaine Hydrochloride Sales by Region (2022-2027) & (Ton)
Table 14. Global Levobupivacaine Hydrochloride Sales Market Share by Region (2022-2027)
Table 15. Global Levobupivacaine Hydrochloride Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Levobupivacaine Hydrochloride Revenue Market Share by Region (2016-2021)
Table 17. Global Levobupivacaine Hydrochloride Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Levobupivacaine Hydrochloride Revenue Market Share by Region (2022-2027)
Table 19. Global Levobupivacaine Hydrochloride Production Capacity by Manufacturers (2016-2021) & (Ton)
Table 20. Global Levobupivacaine Hydrochloride Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Levobupivacaine Hydrochloride Production by Manufacturers (2016-2021) & (Ton)
Table 22. Global Levobupivacaine Hydrochloride Production Market Share by Manufacturers (2016-2021)
Table 23. Global Levobupivacaine Hydrochloride Sales by Manufacturers (2016-2021) & (Ton)
Table 24. Global Levobupivacaine Hydrochloride Sales Share by Manufacturers (2016-2021)
Table 25. Global Levobupivacaine Hydrochloride Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Levobupivacaine Hydrochloride Revenue Share by Manufacturers (2016-2021)
Table 27. Levobupivacaine Hydrochloride Price by Manufacturers 2016-2021 (US$/Ton)
Table 28. Global Levobupivacaine Hydrochloride Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Levobupivacaine Hydrochloride by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Levobupivacaine Hydrochloride as of 2020)
Table 30. Levobupivacaine Hydrochloride Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Levobupivacaine Hydrochloride Product Offered
Table 32. Date of Manufacturers Enter into Levobupivacaine Hydrochloride Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Levobupivacaine Hydrochloride Sales by Type (2016-2021) & (Ton)
Table 35. Global Levobupivacaine Hydrochloride Sales by Type (2022-2027) & (Ton)
Table 36. Global Levobupivacaine Hydrochloride Sales Share by Type (2016-2021)
Table 37. Global Levobupivacaine Hydrochloride Sales Share by Type (2022-2027)
Table 38. Global Levobupivacaine Hydrochloride Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Levobupivacaine Hydrochloride Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Levobupivacaine Hydrochloride Revenue Share by Type (2016-2021)
Table 41. Global Levobupivacaine Hydrochloride Revenue Share by Type (2022-2027)
Table 42. Levobupivacaine Hydrochloride Price by Type (2016-2021) & (US$/Ton)
Table 43. Global Levobupivacaine Hydrochloride Price Forecast by Type (2022-2027) & (US$/Ton)
Table 44. Global Levobupivacaine Hydrochloride Sales by Application (2016-2021) & (Ton)
Table 45. Global Levobupivacaine Hydrochloride Sales by Application (2022-2027) & (Ton)
Table 46. Global Levobupivacaine Hydrochloride Sales Share by Application (2016-2021)
Table 47. Global Levobupivacaine Hydrochloride Sales Share by Application (2022-2027)
Table 48. Global Levobupivacaine Hydrochloride Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Levobupivacaine Hydrochloride Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Levobupivacaine Hydrochloride Revenue Share by Application (2016-2021)
Table 51. Global Levobupivacaine Hydrochloride Revenue Share by Application (2022-2027)
Table 52. Levobupivacaine Hydrochloride Price by Application (2016-2021) & (US$/Ton)
Table 53. Global Levobupivacaine Hydrochloride Price Forecast by Application (2022-2027) & (US$/Ton)
Table 54. North America Levobupivacaine Hydrochloride Sales by Type (2016-2021) & (Ton)
Table 55. North America Levobupivacaine Hydrochloride Sales by Type (2022-2027) & (Ton)
Table 56. North America Levobupivacaine Hydrochloride Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Levobupivacaine Hydrochloride Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Levobupivacaine Hydrochloride Sales by Application (2016-2021) & (Ton)
Table 59. North America Levobupivacaine Hydrochloride Sales by Application (2022-2027) & (Ton)
Table 60. North America Levobupivacaine Hydrochloride Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Levobupivacaine Hydrochloride Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Levobupivacaine Hydrochloride Sales by Country (2016-2021) & (Ton)
Table 63. North America Levobupivacaine Hydrochloride Sales by Country (2022-2027) & (Ton)
Table 64. North America Levobupivacaine Hydrochloride Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Levobupivacaine Hydrochloride Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Levobupivacaine Hydrochloride Sales by Type (2016-2021) & (Ton)
Table 67. Europe Levobupivacaine Hydrochloride Sales by Type (2022-2027) & (Ton)
Table 68. Europe Levobupivacaine Hydrochloride Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Levobupivacaine Hydrochloride Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Levobupivacaine Hydrochloride Sales by Application (2016-2021) & (Ton)
Table 71. Europe Levobupivacaine Hydrochloride Sales by Application (2022-2027) & (Ton)
Table 72. Europe Levobupivacaine Hydrochloride Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Levobupivacaine Hydrochloride Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Levobupivacaine Hydrochloride Sales by Country (2016-2021) & (Ton)
Table 75. Europe Levobupivacaine Hydrochloride Sales by Country (2022-2027) & (Ton)
Table 76. Europe Levobupivacaine Hydrochloride Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Levobupivacaine Hydrochloride Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Levobupivacaine Hydrochloride Sales by Type (2016-2021) & (Ton)
Table 79. Asia Pacific Levobupivacaine Hydrochloride Sales by Type (2022-2027) & (Ton)
Table 80. Asia Pacific Levobupivacaine Hydrochloride Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Levobupivacaine Hydrochloride Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Levobupivacaine Hydrochloride Sales by Application (2016-2021) & (Ton)
Table 83. Asia Pacific Levobupivacaine Hydrochloride Sales by Application (2022-2027) & (Ton)
Table 84. Asia Pacific Levobupivacaine Hydrochloride Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Levobupivacaine Hydrochloride Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Levobupivacaine Hydrochloride Sales by Region (2016-2021) & (Ton)
Table 87. Asia Pacific Levobupivacaine Hydrochloride Sales by Region (2022-2027) & (Ton)
Table 88. Asia Pacific Levobupivacaine Hydrochloride Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Levobupivacaine Hydrochloride Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Levobupivacaine Hydrochloride Sales by Type (2016-2021) & (Ton)
Table 91. Latin America Levobupivacaine Hydrochloride Sales by Type (2022-2027) & (Ton)
Table 92. Latin America Levobupivacaine Hydrochloride Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Levobupivacaine Hydrochloride Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Levobupivacaine Hydrochloride Sales by Application (2016-2021) & (Ton)
Table 95. Latin America Levobupivacaine Hydrochloride Sales by Application (2022-2027) & (Ton)
Table 96. Latin America Levobupivacaine Hydrochloride Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Levobupivacaine Hydrochloride Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Levobupivacaine Hydrochloride Sales by Country (2016-2021) & (Ton)
Table 99. Latin America Levobupivacaine Hydrochloride Sales by Country (2022-2027) & (Ton)
Table 100. Latin America Levobupivacaine Hydrochloride Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Levobupivacaine Hydrochloride Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Levobupivacaine Hydrochloride Sales by Type (2016-2021) & (Ton)
Table 103. Middle East and Africa Levobupivacaine Hydrochloride Sales by Type (2022-2027) & (Ton)
Table 104. Middle East and Africa Levobupivacaine Hydrochloride Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Levobupivacaine Hydrochloride Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Levobupivacaine Hydrochloride Sales by Application (2016-2021) & (Ton)
Table 107. Middle East and Africa Levobupivacaine Hydrochloride Sales by Application (2022-2027) & (Ton)
Table 108. Middle East and Africa Levobupivacaine Hydrochloride Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Levobupivacaine Hydrochloride Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Levobupivacaine Hydrochloride Sales by Country (2016-2021) & (Ton)
Table 111. Middle East and Africa Levobupivacaine Hydrochloride Sales by Country (2022-2027) & (Ton)
Table 112. Middle East and Africa Levobupivacaine Hydrochloride Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Levobupivacaine Hydrochloride Revenue by Country (2022-2027) & (US$ Million)
Table 114. Rundu Pharma Corporation Information
Table 115. Rundu Pharma Description and Major Businesses
Table 116. Rundu Pharma Levobupivacaine Hydrochloride Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 117. Rundu Pharma Levobupivacaine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Rundu Pharma Recent Development
Table 119. Dishman Carbogen Amcis Corporation Information
Table 120. Dishman Carbogen Amcis Description and Major Businesses
Table 121. Dishman Carbogen Amcis Levobupivacaine Hydrochloride Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 122. Dishman Carbogen Amcis Levobupivacaine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Dishman Carbogen Amcis Recent Development
Table 124. Recipharm Corporation Information
Table 125. Recipharm Description and Major Businesses
Table 126. Recipharm Levobupivacaine Hydrochloride Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 127. Recipharm Levobupivacaine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Recipharm Recent Development
Table 129. Shanghai OSD Corporation Information
Table 130. Shanghai OSD Description and Major Businesses
Table 131. Shanghai OSD Levobupivacaine Hydrochloride Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 132. Shanghai OSD Levobupivacaine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Shanghai OSD Recent Development
Table 134. Nanjin Yihua Corporation Information
Table 135. Nanjin Yihua Description and Major Businesses
Table 136. Nanjin Yihua Levobupivacaine Hydrochloride Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 137. Nanjin Yihua Levobupivacaine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Nanjin Yihua Recent Development
Table 139. ASK Pharm Corporation Information
Table 140. ASK Pharm Description and Major Businesses
Table 141. ASK Pharm Levobupivacaine Hydrochloride Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 142. ASK Pharm Levobupivacaine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. ASK Pharm Recent Development
Table 144. Jiangsu Hengrui Medicine Corporation Information
Table 145. Jiangsu Hengrui Medicine Description and Major Businesses
Table 146. Jiangsu Hengrui Medicine Levobupivacaine Hydrochloride Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 147. Jiangsu Hengrui Medicine Levobupivacaine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Jiangsu Hengrui Medicine Recent Development
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Levobupivacaine Hydrochloride Distributors List
Table 152. Levobupivacaine Hydrochloride Customers List
Table 153. Levobupivacaine Hydrochloride Market Trends
Table 154. Levobupivacaine Hydrochloride Market Drivers
Table 155. Levobupivacaine Hydrochloride Market Challenges
Table 156. Levobupivacaine Hydrochloride Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Levobupivacaine Hydrochloride Product Picture
Figure 2. Global Levobupivacaine Hydrochloride Market Share by Type in 2020 & 2027
Figure 3. 99% Purity Product Picture
Figure 4. Other Product Picture
Figure 5. Global Levobupivacaine Hydrochloride Market Share by Application in 2020 & 2027
Figure 6. Surgical Epidural Block
Figure 7. Other
Figure 8. Levobupivacaine Hydrochloride Report Years Considered
Figure 9. Global Levobupivacaine Hydrochloride Capacity, Production and Utilization (2016-2027) & (Ton)
Figure 10. Global Levobupivacaine Hydrochloride Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 11. Global Levobupivacaine Hydrochloride Production Market Share by Region (2016-2021)
Figure 12. Global Levobupivacaine Hydrochloride Production Market Share by Region (2022-2027)
Figure 13. Levobupivacaine Hydrochloride Production Growth Rate in North America (2016-2027) & (Ton)
Figure 14. Levobupivacaine Hydrochloride Production Growth Rate in Europe (2016-2027) & (Ton)
Figure 15. Levobupivacaine Hydrochloride Production Growth Rate in China (2016-2027) & (Ton)
Figure 16. Levobupivacaine Hydrochloride Production Growth Rate in Japan (2016-2027) & (Ton)
Figure 17. Global Levobupivacaine Hydrochloride Sales 2016-2027 (Ton)
Figure 18. Global Levobupivacaine Hydrochloride Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Levobupivacaine Hydrochloride Revenue 2016-2027 (US$ Million)
Figure 20. Global Levobupivacaine Hydrochloride Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 21. Global Levobupivacaine Hydrochloride Sales Market Share by Region (2016-2021)
Figure 22. Global Levobupivacaine Hydrochloride Sales Market Share by Region (2022-2027)
Figure 23. North America Levobupivacaine Hydrochloride Sales YoY (2016-2027) & (Ton)
Figure 24. North America Levobupivacaine Hydrochloride Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Europe Levobupivacaine Hydrochloride Sales YoY (2016-2027) & (Ton)
Figure 26. Europe Levobupivacaine Hydrochloride Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Asia-Pacific Levobupivacaine Hydrochloride Sales YoY (2016-2027) & (Ton)
Figure 28. Asia-Pacific Levobupivacaine Hydrochloride Revenue YoY (2016-2027) & (US$ Million)
Figure 29. Latin America Levobupivacaine Hydrochloride Sales YoY (2016-2027) & (Ton)
Figure 30. Latin America Levobupivacaine Hydrochloride Revenue YoY (2016-2027) & (US$ Million)
Figure 31. Middle East & Africa Levobupivacaine Hydrochloride Sales YoY (2016-2027) & (Ton)
Figure 32. Middle East & Africa Levobupivacaine Hydrochloride Revenue YoY (2016-2027) & (US$ Million)
Figure 33. The Top 10 and Top 5 Players Market Share by Levobupivacaine Hydrochloride Sales in 2020
Figure 34. The Top 10 and Top 5 Players Market Share by Levobupivacaine Hydrochloride Revenue in 2020
Figure 35. Levobupivacaine Hydrochloride Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 36. Global Levobupivacaine Hydrochloride Sales Market Share by Type (2016-2027)
Figure 37. Global Levobupivacaine Hydrochloride Revenue Market Share by Type (2016-2027)
Figure 38. Global Levobupivacaine Hydrochloride Sales Market Share by Application (2016-2027)
Figure 39. Global Levobupivacaine Hydrochloride Revenue Market Share by Application (2016-2027)
Figure 40. North America Levobupivacaine Hydrochloride Sales Market Share by Type (2016-2027)
Figure 41. North America Levobupivacaine Hydrochloride Revenue Market Share by Type (2016-2027)
Figure 42. North America Levobupivacaine Hydrochloride Sales Market Share by Application (2016-2027)
Figure 43. North America Levobupivacaine Hydrochloride Revenue Market Share by Application (2016-2027)
Figure 44. North America Levobupivacaine Hydrochloride Sales Share by Country (2016-2027)
Figure 45. North America Levobupivacaine Hydrochloride Revenue Share by Country (2016-2027)
Figure 46. United States Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 47. Canada Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 48. Europe Levobupivacaine Hydrochloride Sales Market Share by Type (2016-2027)
Figure 49. Europe Levobupivacaine Hydrochloride Revenue Market Share by Type (2016-2027)
Figure 50. Europe Levobupivacaine Hydrochloride Sales Market Share by Application (2016-2027)
Figure 51. Europe Levobupivacaine Hydrochloride Revenue Market Share by Application (2016-2027)
Figure 52. Europe Levobupivacaine Hydrochloride Sales Share by Country (2016-2027)
Figure 53. Europe Levobupivacaine Hydrochloride Revenue Share by Country (2016-2027)
Figure 54. Germany Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 55. France Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 56. U.K. Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 57. Italy Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 58. Russia Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 59. Asia Pacific Levobupivacaine Hydrochloride Sales Market Share by Type (2016-2027)
Figure 60. Asia Pacific Levobupivacaine Hydrochloride Revenue Market Share by Type (2016-2027)
Figure 61. Asia Pacific Levobupivacaine Hydrochloride Sales Market Share by Application (2016-2027)
Figure 62. Asia Pacific Levobupivacaine Hydrochloride Revenue Market Share by Application (2016-2027)
Figure 63. Asia Pacific Levobupivacaine Hydrochloride Sales Share by Region (2016-2027)
Figure 64. Asia Pacific Levobupivacaine Hydrochloride Revenue Share by Region (2016-2027)
Figure 65. China Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 66. Japan Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 67. South Korea Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 68. India Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 69. Australia Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 70. China Taiwan Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 71. Indonesia Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 72. Thailand Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 73. Malaysia Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 74. Latin America Levobupivacaine Hydrochloride Sales Market Share by Type (2016-2027)
Figure 75. Latin America Levobupivacaine Hydrochloride Revenue Market Share by Type (2016-2027)
Figure 76. Latin America Levobupivacaine Hydrochloride Sales Market Share by Application (2016-2027)
Figure 77. Latin America Levobupivacaine Hydrochloride Revenue Market Share by Application (2016-2027)
Figure 78. Latin America Levobupivacaine Hydrochloride Sales Share by Country (2016-2027)
Figure 79. Latin America Levobupivacaine Hydrochloride Revenue Share by Country (2016-2027)
Figure 80. Mexico Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 81. Brazil Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 82. Argentina Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 83. Middle East and Africa Levobupivacaine Hydrochloride Sales Market Share by Type (2016-2027)
Figure 84. Middle East and Africa Levobupivacaine Hydrochloride Revenue Market Share by Type (2016-2027)
Figure 85. Middle East and Africa Levobupivacaine Hydrochloride Sales Market Share by Application (2016-2027)
Figure 86. Middle East and Africa Levobupivacaine Hydrochloride Revenue Market Share by Application (2016-2027)
Figure 87. Middle East and Africa Levobupivacaine Hydrochloride Sales Share by Country (2016-2027)
Figure 88. Middle East and Africa Levobupivacaine Hydrochloride Revenue Share by Country (2016-2027)
Figure 89. Turkey Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 90. Saudi Arabia Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 91. UAE Levobupivacaine Hydrochloride Revenue (2016-2027) & (US$ Million)
Figure 92. Levobupivacaine Hydrochloride Value Chain
Figure 93. Levobupivacaine Hydrochloride Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed